Selected research
Industry Research
Pet Disease Diagnostic Reagent Industry Research Report 2026
Market perspective
The global Pet Disease Diagnostic Reagent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pet Disease Diagnostic Reagent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pet Disease Diagnostic Reagent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pet Disease Diagnostic Reagent include Nanjing Synthgene Medical Technology, USTAR BIOTECHNOLOGIES (HANGZHOU), Hangzhou LifeReal Biotechnology, Harbin Guosheng Biomedical Laboratory, Idvet, IDEXX, Diogene and Bio-Rad, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pet Disease Diagnostic Reagent market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Disease Diagnostic Reagent Market by Company
Nanjing Synthgene Medical Technology
USTAR BIOTECHNOLOGIES (HANGZHOU)
Hangzhou LifeReal Biotechnology
Harbin Guosheng Biomedical Laboratory
Idvet
IDEXX
Diogene
Bio-Rad
Pet Disease Diagnostic Reagent Segment by Type
Nucleic Acid Detection Reagents
Colloidal Gold Detection Reagents
Enzyme-linked Immunosorbent Assay Reagents
Fluorescent PCR Detection Reagents
Pet Disease Diagnostic Reagent Segment by Application
Cat
Dog
Others
Pet Disease Diagnostic Reagent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Diagnostic Reagent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pet Disease Diagnostic Reagent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pet Disease Diagnostic Reagent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pet Disease Diagnostic Reagent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Detection Reagents
- Colloidal Gold Detection Reagents
- Enzyme-linked Immunosorbent Assay Reagents
- Fluorescent PCR Detection Reagents
Applications
- Cat
- Dog
- Others
Companies covered
- Nanjing Synthgene Medical Technology
- USTAR BIOTECHNOLOGIES (HANGZHOU)
- Hangzhou LifeReal Biotechnology
- Harbin Guosheng Biomedical Laboratory
- Idvet
- IDEXX
- Diogene
- Bio-Rad
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pet Disease Diagnostic Reagent Market Size (2021-2032)
- 2.2.2 Global Pet Disease Diagnostic Reagent Sales (2021-2032)
- 2.2.3 Global Pet Disease Diagnostic Reagent Market Average Price (2021-2032)
- 2.3 Pet Disease Diagnostic Reagent by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nucleic Acid Detection Reagents
- 2.3.3 Colloidal Gold Detection Reagents
- 2.3.4 Enzyme-linked Immunosorbent Assay Reagents
- 2.3.5 Fluorescent PCR Detection Reagents
- 2.4 Pet Disease Diagnostic Reagent by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cat
- 2.4.3 Dog
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pet Disease Diagnostic Reagent Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pet Disease Diagnostic Reagent Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pet Disease Diagnostic Reagent Revenue of Manufacturers (2021-2026)
- 3.4 Global Pet Disease Diagnostic Reagent Average Price by Manufacturers (2021-2026)
- 3.5 Global Pet Disease Diagnostic Reagent Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pet Disease Diagnostic Reagent, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pet Disease Diagnostic Reagent, Product Type & Application
- 3.8 Global Manufacturers of Pet Disease Diagnostic Reagent, Established Date
- 3.9 Global Pet Disease Diagnostic Reagent Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Nanjing Synthgene Medical Technology
- 4.1.1 Nanjing Synthgene Medical Technology Company Information
- 4.1.2 Nanjing Synthgene Medical Technology Business Overview
- 4.1.3 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Product Portfolio
- 4.1.5 Nanjing Synthgene Medical Technology Recent Developments
- 4.2 USTAR BIOTECHNOLOGIES (HANGZHOU)
- 4.2.1 USTAR BIOTECHNOLOGIES (HANGZHOU) Company Information
- 4.2.2 USTAR BIOTECHNOLOGIES (HANGZHOU) Business Overview
- 4.2.3 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Product Portfolio
- 4.2.5 USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Developments
- 4.3 Hangzhou LifeReal Biotechnology
- 4.3.1 Hangzhou LifeReal Biotechnology Company Information
- 4.3.2 Hangzhou LifeReal Biotechnology Business Overview
- 4.3.3 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Product Portfolio
- 4.3.5 Hangzhou LifeReal Biotechnology Recent Developments
- 4.4 Harbin Guosheng Biomedical Laboratory
- 4.4.1 Harbin Guosheng Biomedical Laboratory Company Information
- 4.4.2 Harbin Guosheng Biomedical Laboratory Business Overview
- 4.4.3 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Product Portfolio
- 4.4.5 Harbin Guosheng Biomedical Laboratory Recent Developments
- 4.5 Idvet
- 4.5.1 Idvet Company Information
- 4.5.2 Idvet Business Overview
- 4.5.3 Idvet Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Idvet Pet Disease Diagnostic Reagent Product Portfolio
- 4.5.5 Idvet Recent Developments
- 4.6 IDEXX
- 4.6.1 IDEXX Company Information
- 4.6.2 IDEXX Business Overview
- 4.6.3 IDEXX Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 IDEXX Pet Disease Diagnostic Reagent Product Portfolio
- 4.6.5 IDEXX Recent Developments
- 4.7 Diogene
- 4.7.1 Diogene Company Information
- 4.7.2 Diogene Business Overview
- 4.7.3 Diogene Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Diogene Pet Disease Diagnostic Reagent Product Portfolio
- 4.7.5 Diogene Recent Developments
- 4.8 Bio-Rad
- 4.8.1 Bio-Rad Company Information
- 4.8.2 Bio-Rad Business Overview
- 4.8.3 Bio-Rad Pet Disease Diagnostic Reagent Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bio-Rad Pet Disease Diagnostic Reagent Product Portfolio
- 4.8.5 Bio-Rad Recent Developments
5 Global Pet Disease Diagnostic Reagent Market Scenario by Region
- 5.1 Global Pet Disease Diagnostic Reagent Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pet Disease Diagnostic Reagent Sales by Region: 2021-2032
- 5.2.1 Global Pet Disease Diagnostic Reagent Sales by Region: 2021-2026
- 5.2.2 Global Pet Disease Diagnostic Reagent Sales by Region: 2027-2032
- 5.3 Global Pet Disease Diagnostic Reagent Revenue by Region: 2021-2032
- 5.3.1 Global Pet Disease Diagnostic Reagent Revenue by Region: 2021-2026
- 5.3.2 Global Pet Disease Diagnostic Reagent Revenue by Region: 2027-2032
- 5.4 North America Pet Disease Diagnostic Reagent Market Facts & Figures by Country
- 5.4.1 North America Pet Disease Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 5.4.3 North America Pet Disease Diagnostic Reagent Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pet Disease Diagnostic Reagent Market Facts & Figures by Country
- 5.5.1 Europe Pet Disease Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 5.5.3 Europe Pet Disease Diagnostic Reagent Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pet Disease Diagnostic Reagent Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pet Disease Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pet Disease Diagnostic Reagent Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pet Disease Diagnostic Reagent Market Facts & Figures by Country
- 5.7.1 South America Pet Disease Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 5.7.3 South America Pet Disease Diagnostic Reagent Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pet Disease Diagnostic Reagent Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pet Disease Diagnostic Reagent Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pet Disease Diagnostic Reagent Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pet Disease Diagnostic Reagent Sales by Type (2021-2032)
- 6.1.1 Global Pet Disease Diagnostic Reagent Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pet Disease Diagnostic Reagent Sales Market Share by Type (2021-2032)
- 6.2 Global Pet Disease Diagnostic Reagent Revenue by Type (2021-2032)
- 6.2.1 Global Pet Disease Diagnostic Reagent Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pet Disease Diagnostic Reagent Revenue Market Share by Type (2021-2032)
- 6.3 Global Pet Disease Diagnostic Reagent Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pet Disease Diagnostic Reagent Sales by Application (2021-2032)
- 7.1.1 Global Pet Disease Diagnostic Reagent Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pet Disease Diagnostic Reagent Sales Market Share by Application (2021-2032)
- 7.2 Global Pet Disease Diagnostic Reagent Revenue by Application (2021-2032)
- 7.2.1 Global Pet Disease Diagnostic Reagent Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pet Disease Diagnostic Reagent Revenue Market Share by Application (2021-2032)
- 7.3 Global Pet Disease Diagnostic Reagent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pet Disease Diagnostic Reagent Value Chain Analysis
- 8.1.1 Pet Disease Diagnostic Reagent Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pet Disease Diagnostic Reagent Production Mode & Process
- 8.2 Pet Disease Diagnostic Reagent Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pet Disease Diagnostic Reagent Distributors
- 8.2.3 Pet Disease Diagnostic Reagent Customers
9 Global Pet Disease Diagnostic Reagent Analyzing Market Dynamics
- 9.1 Pet Disease Diagnostic Reagent Industry Trends
- 9.2 Pet Disease Diagnostic Reagent Industry Drivers
- 9.3 Pet Disease Diagnostic Reagent Industry Opportunities and Challenges
- 9.4 Pet Disease Diagnostic Reagent Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst